Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving hydrolase
Reexamination Certificate
2011-08-30
2011-08-30
Kemmerer, Elizabeth C (Department: 1649)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving hydrolase
C435S024000, C435S004000, C435S803000, C436S173000
Reexamination Certificate
active
08008036
ABSTRACT:
A method for confirming a diagnosis of autism in an individual comprises obtaining a sample of feces from an individual, determining a quantitative level of chymotrypsin present in the sample, and comparing the quantitative level of fecal chymotrypsin in the stool sample of the person having autism to a stool sample from an individual that has a normal fecal chymotrypsin level and does not have autism and confirming a diagnosis of autism based on the measurement of the quantitative level of fecal chymoptrypsin.
REFERENCES:
patent: 3002883 (1961-10-01), Butt et al.
patent: 3223594 (1965-12-01), Serge
patent: 3357894 (1967-12-01), Jose et al.
patent: 3515642 (1970-06-01), Mima et al.
patent: 3574819 (1971-04-01), Gross et al.
patent: 3940478 (1976-02-01), Kurtz
patent: 4079125 (1978-03-01), Sipos
patent: 4145410 (1979-03-01), Sears
patent: 4241046 (1980-12-01), Papahadjopoulos et al.
patent: 4826679 (1989-05-01), Roy
patent: 5190775 (1993-03-01), Klose
patent: 5250418 (1993-10-01), Moller et al.
patent: 5324514 (1994-06-01), Sipos
patent: 5436319 (1995-07-01), Kung et al.
patent: 5437319 (1995-08-01), Garuglieri
patent: 5439935 (1995-08-01), Rawlings et al.
patent: 5460812 (1995-10-01), Sipos
patent: 5476661 (1995-12-01), Pillai et al.
patent: 5527678 (1996-06-01), Blaser et al.
patent: 5585115 (1996-12-01), Sherwood et al.
patent: 5607863 (1997-03-01), Chandler
patent: 5648335 (1997-07-01), Lewis et al.
patent: 5674532 (1997-10-01), Atzl et al.
patent: 5686311 (1997-11-01), Shaw
patent: 5750104 (1998-05-01), Sipos
patent: 5776917 (1998-07-01), Blank et al.
patent: 5858758 (1999-01-01), Hillman et al.
patent: 5952178 (1999-09-01), Lapidus et al.
patent: 5958875 (1999-09-01), Longo et al.
patent: 5985891 (1999-11-01), Rowe
patent: 6011001 (2000-01-01), Navia et al.
patent: 6013286 (2000-01-01), Klose
patent: 6020310 (2000-02-01), Beck et al.
patent: 6020314 (2000-02-01), McMichael
patent: 6153236 (2000-11-01), Wu et al.
patent: 6187309 (2001-02-01), McMichael et al.
patent: 6197746 (2001-03-01), Beck et al.
patent: 6210950 (2001-04-01), Johnson et al.
patent: 6251478 (2001-06-01), Pacifico et al.
patent: 6261613 (2001-07-01), Narayanaswamy et al.
patent: 6280726 (2001-08-01), Weinrauch et al.
patent: 6309669 (2001-10-01), Setterstrom et al.
patent: 6399101 (2002-06-01), Frontanes et al.
patent: 6482839 (2002-11-01), Thornfeldt
patent: 6534063 (2003-03-01), Fallon
patent: 6534259 (2003-03-01), Wakefield
patent: 6632429 (2003-10-01), Fallon
patent: 6660831 (2003-12-01), Fallon
patent: 6727073 (2004-04-01), Moore et al.
patent: 6743447 (2004-06-01), Labergerie et al.
patent: 6797291 (2004-09-01), Richardson
patent: 6835397 (2004-12-01), Lee et al.
patent: 6852487 (2005-02-01), Barany et al.
patent: 7101573 (2006-09-01), Szymczak et al.
patent: 7129053 (2006-10-01), Reiter et al.
patent: 7138123 (2006-11-01), Fallon
patent: 2002/0037284 (2002-03-01), Fallon
patent: 2002/0081628 (2002-06-01), Fallon
patent: 2002/0090653 (2002-07-01), Fallon
patent: 2003/0097122 (2003-05-01), Ganz et al.
patent: 2004/0057944 (2004-03-01), Galle et al.
patent: 2004/0057962 (2004-03-01), Timmerman
patent: 2004/0071683 (2004-04-01), Fallon
patent: 2004/0076590 (2004-04-01), Wilkins
patent: 2004/0101562 (2004-05-01), Maio
patent: 2004/0121002 (2004-06-01), Lee et al.
patent: 2004/0209790 (2004-10-01), Sava et al.
patent: 2005/0187130 (2005-08-01), Booker et al.
patent: 2006/0105379 (2006-05-01), Wu et al.
patent: 2006/0182728 (2006-08-01), Fallon
patent: 2006/0183180 (2006-08-01), Fallon
patent: 2006/0198838 (2006-09-01), Fallon
patent: 2006/0259995 (2006-11-01), Cayouette et al.
patent: 2007/0053895 (2007-03-01), Fallon
patent: 2007/0116695 (2007-05-01), Fallon
patent: 2008/0058282 (2008-03-01), Fallon
patent: 2008/0152637 (2008-06-01), Fallon
patent: 2008/0161265 (2008-07-01), Fallon et al.
patent: 2008/0166334 (2008-07-01), Fallon
patent: 2008/0219966 (2008-09-01), Fallon
patent: 2008/0254009 (2008-10-01), Finegold
patent: 2008/0279839 (2008-11-01), Schuler et al.
patent: 2008/0317731 (2008-12-01), Gramatikova et al.
patent: 2009/0130081 (2009-05-01), Fallon
patent: 2009/0232789 (2009-09-01), Fallon
patent: 2009/0263372 (2009-10-01), Fallon
patent: 2009/0285790 (2009-11-01), Fallon
patent: 2009/0286270 (2009-11-01), Fallon
patent: 2009/0324572 (2009-12-01), Fallon
patent: 2009/0324730 (2009-12-01), Fallon
patent: 2010/0092447 (2010-04-01), Fallon
patent: 2010/0169409 (2010-07-01), Fallon et al.
patent: 2010/0233218 (2010-09-01), Fallon
patent: 2010/0260857 (2010-10-01), Fallon et al.
patent: 4332985 (1995-03-01), None
patent: 0451484 (1991-10-01), None
patent: 0564739 (1993-10-01), None
patent: 0564739 (1995-04-01), None
patent: 2347742 (2000-09-01), None
patent: 62230714 (1987-10-01), None
patent: WO 95/22344 (1995-08-01), None
patent: WO 98/22499 (1998-05-01), None
patent: WO 98/22499 (1998-07-01), None
patent: WO 98/52593 (1998-11-01), None
patent: WO 99/64059 (1999-12-01), None
patent: WO 99/64059 (1999-12-01), None
patent: WO 00/09142 (2000-02-01), None
patent: WO 01/27612 (2001-04-01), None
patent: WO 01/43764 (2001-06-01), None
patent: WO 01/27612 (2001-10-01), None
patent: WO 01/43764 (2001-11-01), None
patent: WO 02/14537 (2002-02-01), None
patent: WO 02/14537 (2002-05-01), None
patent: WO 2009/114757 (2009-09-01), None
patent: WO 2010/002972 (2010-01-01), None
patent: WO 2010/080830 (2010-07-01), None
patent: WO 2010/080835 (2010-07-01), None
Amendment dated Mar. 24, 2010 in Reply to Final Office Action dated Sep. 24, 2009 for U.S. Appl. No. 12/046,252.
Levy, et al. Relationship of dietary intake to gastrointestinal symptoms in children with autistic spectrum disorders. Biol Psychiatry. Feb. 15, 2007;61(4):492-7.
Notice of Allowance dated Apr. 15, 2011 for U.S. Appl. No. 12/487,868.
Notice of Allowance dated Apr. 29, 2011 for U.S. Appl. No. 12/046,402.
Office Action dated Apr. 27, 2011 for U.S. Appl. No. 10/681,018.
Office Action dated Apr. 28, 2011 for U.S. Appl. No. 12/283,090.
Sturmey. Secretin is an ineffective treatment for pervasive developmental disabilities: a review of 15 double-blind randomized controlled trials. Res Dev Disabil. Jan.-Feb. 2005;26(1):87-97.
Ang, et al. Biological role and regulation of the universally conserved heat shock proteins. J Biol Chem. Dec. 25, 1991;266(36):24233-6.
Arribas, et al. A comparative study of the chymotrypsin-like activity of the rat liver multicatalytic proteinase and the ClpP fromEscherichia coli. J Biol Chem. Oct. 5, 1993;268(28):21165-71, (Abstract only).
Arrigo, et al. Expression of heat shock proteins during development in Drosophila. Results Probl Cell Differ. 1991;17:106-19, (Abstract only).
Austic. Development and adaptation of protein digestion. J Nutr. May 1985;115(5):686-97.
Awazuhara, et al. Antigenicity of the proteins in soy lecithin and soy oil in soybean allergy. Clin Exp Allergy. Dec. 1998;28(12):1559-64.
Beilmann, et al. Neoexpression of the c-met/hepatocyte growth factor-scatter factor receptor gene in activated monocytes. Blood. Dec. 1, 1997;90(11):4450-8.
Borowitz, et al. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee. J Pediatr. Nov. 1995; I27(5):681-4.
Boyd, et al. Positively charged amino acid residues can act as topogenic determinants in membrane proteins. Proc Natl Acad Sci U S A. Dec. 1989;86(23):9446-50.
Bruhat, et al. Amino acid limitation induces expression of CHOP, a CCAAT/enhancer binding protein-related gene, at both transcriptional and post-transcriptional levels. J Biol Chem. Jul. 11, 1997;272(28):17588-93.
Carroccio, et al. Secondary impairment of pancreatic function as a cause of severe malabsorption in intestinal giardiasis: a case report. Am J Trop Med Hyg. Jun. 1997;56(6):599-602, (Abstract only).
Carroccio, et al. Secretin-cerulein test and fecal chymotrypsin concentration in children with intestinal giardiasis. Int J Pancreatol. Oct. 1993;14(2):175-80, (Abstract only).
Cassidy, et al. A new concept for the mechanism of action of chymotrypsin: the role of the low-barrier hydrogen bond. Biochemistry. Apr. 15, 1997;36(15):
Ballard Kimberly A
Curemark LLC
Kemmerer Elizabeth C
Wilson Sonsini Goodrich & Rosati
LandOfFree
Method for identifying autistic individuals amenable to... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for identifying autistic individuals amenable to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for identifying autistic individuals amenable to... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2718609